METROSIL
2.3.2016 04:01:55 CET | Business Wire | Press release
Metrosil , the world leader in silicon carbide non-linear resistors (called varistors) today announced the launch of its new range of De-Excitation Units - the “Metrosil 8000 Series”, designed to protect large electrical generators. The all-new 8000 Series (protected by Registered Design) has been developed around an improved ergonomic structure, an industry first, providing not only protection for the varistor discs, but also simplifying the installation of the units. Another unique feature is the inclusion of a high energy test certificate with every 8000 Series unit, providing proof that the varistors perform as required. De-Excitation varistors protect electricity generating equipment (for example in hydropower and nuclear installations) from the damaging effects of powerful high energy surges.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160301006459/en/
8000 Series features include:
- Protective bar to prevent accidental disc damage
- Anti-tamper device to ensure unit integrity
- Ergonomic handles for easy carrying and installation
- Robust, easy-access connection points
- Range of standard footprints enables consistent installation
- Nameplate –permanently displays the unit’s specification details
- Each unit shipped with certification of high energy testing
- Clearly labelled with High Energy Test “Pass” badge
James O’Brien, Metrosil’s Product Group Director, commented “Metrosil constantly innovates and responds to customer feedback. With its new design, anti-tamper and ergonomic features, the 8000 Series is a more robust, long-lasting product. All Metrosil excitation products are tested to 100% of its specification – it’s part of what makes us unique in the industry, and we’re thrilled to launch another Metrosil first for the power generation industry.”
The Metrosil commercial team will be showing the 8000 Series at industry trade shows and also to individual utilities and power generation companies. To arrange a Metrosil 8000 Series visit, email requests should be sent to Ian Rowley, Metrosil’s Business Development Manager: ianrowley@mimaterials.com .
Ends
About Metrosil
Metrosil is the leading brand of high performance over-voltage protection devices for a wide range of power generation and transmission applications around the globe. It is a product of M&I Materials Limited in Manchester, UK. Since 1936, millions of Metrosil varistors have been sold throughout the world, used in flagship power projects including:
- Three Gorges Hydroelectric Dam, China
- La Grande, Canada
- Grand Coulee Dam, USA
- Itaipu, Brazil/Paraguay
About M&I Materials Limited
M&I Materials Limited is an international manufacturing company producing Specialist Materials for Industry and Science to customers located in more than sixty countries worldwide. www.mimaterials.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20160301006459/en/
Contact:
M&I Materials Ltd
Ian Rowley, Metrosil Business Development
Manager
Tel: +44 (0) 161 864 5490
E-mail: ianrowley@mimaterials.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex to Present New Data on ALYFTREK® at the North American Cystic Fibrosis Conference9.10.2026 19:15:00 CEST | Press release
- Data on ALYFTREK in children ages 2 to 5 years demonstrate recovery of pancreatic function in some children –- Additional abstracts on clinical and real-world evidence on CFTR modulators also presented - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) 2 to 5 years old open-label extension study, highlighting recovery of exocrine pancreatic function in some children in that age group, allowing those children to discontinue pancreatic enzyme replacement therapy (PERT). Pancreatic exocrine insufficiency in children with cystic fibrosis (CF) was previously believed to be irreversible. These data were presented at the North American Cystic Fibrosis Conference (NACFC). “The data presented at NACFC underscore the safety and efficacy of our CF medicines in the real world and in clinical trials in younger age groups. The data from the Phase 3 open-label study in 2 to 5 year olds evaluating exocrine p
Andersen Consulting udvider med TalentSmartEQ for at fremme lederskab og virksomhedstransformation9.10.2026 18:48:00 CEST | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for humankapital gennem en samarbejdsaftale med TalentSmartEQ, en San Diego-baseret virksomhed, der har fokus på at skabe praktiske, engagerende og handlingsorienterede læringsoplevelser med udgangspunkt i emotionel intelligens (EQ) og lederudvikling. I mere end to årtier har TalentSmartEQ arbejdet sammen med organisationer verden over med henblik på at udvikle ledelseskompetencer ved hjælp af emotionel intelligens og dermed styrke medarbejderengagement, teamwork og de samlede resultater. Virksomheden kombinerer forskningsbaserede metoder med praktiske læringsforløb, vurderinger, coaching og skræddersyede programmer, der skal omsætte opbygningen af emotionel intelligens til vedvarende ændringer i adfærden på arbejdspladsen. Som førende aktør i branchen samarbejder TalentSmartEQ med organisationer lige fra Fortune 500-virksomheder til offentlige myndigheder og privatejede virksomheder. "Organisationer stiller stadig større krav til dere
Verdant Rock Receives A (low) Financial Strength Rating from Morningstar DBRS, Adding a Second International Investment-Grade Assessment9.10.2026 16:00:00 CEST | Press release
Verdant Rock now holds Financial Strength Ratings from both Fitch Ratings and Morningstar DBRS, providing counterparties with dual-agency confirmation and reinforcing the security architecture behind each financial guarantee Verdant Rock Limited, a Bermuda Monetary Authority-regulated Class 3B insurance company, has received an A (low) Financial Strength Rating from Morningstar DBRS. The rating reflects Verdant Rock’s financial strength and its capacity to meet policyholder obligations as an investment-grade financial guarantor for Emerging Markets credit. Morningstar DBRS is a global credit rating agency with coverage across North America, Europe, Asia, and Latin America. Its assessment of Verdant Rock reflects the company’s strong projected earnings ability, robust risk profile, sound liquidity, and good capitalization. Morningstar DBRS also assigned an A (low) Issuer Rating to Verdant Rock. The rating follows Verdant Rock’s BBB+ Long-Term Insurer Financial Strength Rating with a Sta
Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions9.10.2026 15:17:00 CEST | Press release
We think Gartner recognizes Tecnotree's open, governed approach to agentic AI as operators make AI the engine of their revenue operations Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, today announced that Gartner has positioned it as a Visionary in the first-ever Magic Quadrant for AI-Enabled CSP Marketing and Sales Solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261009905430/en/ Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions A new category for a new operating model. CSPs are fighting saturated markets, rising acquisition costs, and accelerating churn. They are responding with AI-driven automation across the full revenue cycle, from segmentation and campaigns to lead management, CPQ, and renewals, increasingly executed by autonomous agents. According to us, Gartner creation of this Magi
Positive New Data on Corcym’s Perceval Plus Sutureless Aortic Heart Valve Encompasses up to 7-Year Follow-up9.10.2026 15:15:00 CEST | Press release
Data Presented at Annual Meeting of European Association for Cardio-Thoracic Surgery (EACTS), Along with 6 Perceval Plus E-PostersEACTS Also Marks Commercial Launch of TriMemo and Memo 4D Curve, Innovative Repair Devices for Tricuspid and Mitral Valves Corcym, a global medical device company dedicated to cardiac surgery, today announced that positive mid-term data from a sub-analysis of its Perceval Plus sutureless aortic heart valve as part of its MANTRA clinical trial was featured in an oral presentation today at the annual meeting of the European Association for Cardio-Thoracic Surgery (EACTS). The study is the longest follow-up available for Perceval Plus and the FREE tissue treatment from an international multicenter study, and demonstrated excellent durability, safety and quality of life improvements. Perceval Plus is the only sutureless and collapsible aortic surgical heart valve. Its unique design performs in any surgical scenario and is optimal for endoscopy and robotics. The
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom